Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
Olga Sánchez‐Pernaute, Fredeswinda Romero-Bueno, Albert Selva-O’Callaghan
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Pneumonia2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineIntensive care medicineVirologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19